Related Experiment Video
Updated: Jul 6, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
[Hypersexuality in Parkinson's Disease]
1Okayama Neurology Clinic.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|January 20, 2026
Summary
Hypersexuality is a side effect of Parkinson's disease (PD) treatments, affecting 3-8% of patients, especially young males. Treatment involves adjusting dopamine replacement therapy to improve quality of life.
Area of Science:
- Neurology
- Psychiatry
- Pharmacology
Background:
- Parkinson's disease (PD) patients frequently develop hypersexuality, a symptom of impulse control disorders (ICDs).
- Hypersexuality significantly impacts patient quality of life and affects spouses and caregivers.
- This condition is linked to dopamine replacement therapy used in PD management.
Purpose of the Study:
- To summarize the occurrence, risk factors, and management of hypersexuality in Parkinson's disease patients.
- To highlight the association between dopamine replacement therapy and hypersexuality.
- To inform treatment strategies for this challenging side effect.
Main Methods:
- Literature review and synthesis of existing studies on hypersexuality in Parkinson's disease.
- Analysis of prevalence rates, associated risk factors, and implicated medications.
- Examination of current treatment approaches for dopamine-induced hypersexuality.
Main Results:
- Hypersexuality affects 3-8% of Parkinson's disease patients, predominantly young males.
- Risk factors include cognitive impairment, depression history, pathological gambling, and personality traits.
- Dopamine agonists are more frequently associated with hypersexuality than levodopa, with an average medication use duration of 6.5 years.
Conclusions:
- Hypersexuality is a significant burden in Parkinson's disease, necessitating careful medication management.
- Adjusting or discontinuing dopamine replacement therapy, especially dopamine agonists, is the primary treatment strategy.
- Careful drug selection is crucial for high-risk patients, particularly young males, to mitigate hypersexuality development.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...